Literature DB >> 1615137

Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline.

M D Lee1, P G Clifton.   

Abstract

Experiment 1 showed that the reduction of intake produced by 5 or 10 mg/kg fluoxetine in rats eating either a solid or a liquid meal was partially antagonised by 1 mg/kg of the 5HT1/5HT2 antagonist metergoline but not by 1 mg/kg of the 5HT2 antagonist ketanserin. Experiment 2 examined the meal patterning of rats given 5 mg/kg fluoxetine and 1 mg/kg metergoline. Fluoxetine alone increased the latency to feed, reduced meal size and shifted the inter-pellet interval (IPI) distribution to the right. Metergoline alone had little immediate effect on food intake or other feeding parameters but partially reversed the reduction of food intake produced by fluoxetine. There was a complete reversal of the increased latency to feed and a partial reversal of the depression of meal size. However, the rightward shift of the IPI distribution caused by fluoxetine, which indicated a depression of feeding rate, was more pronounced after combined treatment. We conclude that fluoxetine reduces food intake by enhancing satiety through a serotonergic dependent mechanism but reduces feeding rate through a separate mechanism, whose neurochemical basis remains to be established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615137     DOI: 10.1007/bf02245162

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

Review 1.  Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system.

Authors:  S Garattini; T Mennini; C Bendotti; R Invernizzi; R Samanin
Journal:  Appetite       Date:  1986       Impact factor: 3.868

2.  Evidence that blockade of post-synaptic 5-HT1 receptors elicits feeding in satiated rats.

Authors:  C T Dourish; M L Clark; A Fletcher; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Anorectic properties of a new long acting serotonin uptake inhibitor.

Authors:  C Dumont; J Laurent; A Grandadam; J R Boissier
Journal:  Life Sci       Date:  1981-04-27       Impact factor: 5.037

4.  Ketanserin antagonises the anorectic effect of DL-fenfluramine in the rat.

Authors:  G Hewson; G E Leighton; R G Hill; J Hughes
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

5.  A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.

Authors:  D T Wong; F P Bymaster; J S Horng; B B Molloy
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

6.  Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine.

Authors:  P Willner; J McGuirk; G Phillips; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat.

Authors:  R Samanin; T Mennini; C Bendotti; D Barone; S Caccia; S Garattini
Journal:  Neuropharmacology       Date:  1989-05       Impact factor: 5.250

8.  Suppression of food intake in rats by fluoxetine: comparison of enantiomers and effects of serotonin antagonists.

Authors:  D T Wong; L R Reid; P G Threlkeld
Journal:  Pharmacol Biochem Behav       Date:  1988-10       Impact factor: 3.533

9.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline.

Authors:  J E Blundell; C J Latham
Journal:  Pharmacol Biochem Behav       Date:  1980-05       Impact factor: 3.533

View more
  9 in total

1.  A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour.

Authors:  Zoë D Thornton-Jones; Guy A Kennett; Steven P Vickers; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2007-03-20       Impact factor: 4.530

2.  Fluoxetine prevents 8-OH-DPAT-induced hyperphagia in Fischer inbred rats.

Authors:  Chandra Suma Johnson Miryala; Navin Maswood; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2011-01-28       Impact factor: 3.533

Review 3.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Behavioural evidence that d-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype.

Authors:  S P Vickers; P G Clifton; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 5.  Lorcaserin for the treatment of obesity.

Authors:  L M Redman; E Ravussin
Journal:  Drugs Today (Barc)       Date:  2010-12       Impact factor: 2.245

6.  Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Authors:  Nima Davoodi; Mikhail Kalinichev; Sergei A Korneev; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

7.  Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice.

Authors:  J J Lucas; A Yamamoto; K Scearce-Levie; F Saudou; R Hen
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

8.  Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat.

Authors:  Abegale W Hartfield; Nicholas A Moore; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2003-03-26       Impact factor: 4.530

9.  Anxiolytic profile of fluoxetine as monitored following repeated administration in animal rat model of chronic mild stress.

Authors:  Muhammad Farhan; Darakshan Jabeen Haleem
Journal:  Saudi Pharm J       Date:  2015-03-20       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.